πŸ‡ΊπŸ‡Έ FDA
Patent

US 9290512

Activators of human pyruvate kinase

granted A61KA61K31/445A61K31/495

Quick answer

US patent 9290512 (Activators of human pyruvate kinase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/445, A61K31/495, A61K31/496, A61K31/5025